Academic Journals Database
Disseminating quality controlled scientific knowledge

Prevalence of antibodies to Hepatitis C virus among Nigerian patients with HIV infection

Author(s): Petrus Uchenna Inyama | Chigozie Jesse Uneke | Greg Ike Anyanwu | Okonkwo Moses Njoku | Julia Hauwa Idoko | John Alechenu Idoko

Journal: Online Journal of Health & Allied Sciences
ISSN 0972-5997

Volume: 4;
Issue: 2;
Date: 2005;
Original page

Keywords: Hepatitis C virus | HIV | Nigeria

Nigeria belongs to the group of countries highly endemic for viral hepatitis; unfortunately information on the prevalence of hepatitis C amongst patients with HIV in Nigeria is very scarce. This hospital-based investigation was conducted at two major hospitals in Jos, Nigeria from June 2002 through May 2003. Serum samples from 490 confirmed HIV infected patients were assayed for the presence of antibodies to HCV, using a third generation enzyme linked immunosorbent assay. Twenty eight (5.7%; 95% CI 3.66-7.76%) of the patients had antibodies to HCV. The prevalence of HCV antibodies was higher among the males (7.5%; 95% CI 3.83-11.09%) than the females (4.5%; 95% CI 2.10-6.88%). Statistical analysis showed no significant difference (x2 = 1.917, df =1, p=0.05). Individuals of the age group 41-50 years had the highest prevalence of HCV antibodies (15.4%; 95% CI. 7.37-23.29%), followed by those of age group 31-40 years (7.4%; 95%, CI 3.70-11.20%). A significant difference was observed in the association between age and prevalence of HCV antibodies (x2 = 24.151, df = 4, p =0.05). Early diagnosis of HCV in people with HIV infection is advocated to reduce risk of HCV related advanced liver disease.

Tango Jona
Tangokurs Rapperswil-Jona

     Affiliate Program